http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014171646-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3164a963ca21cec1151213cb1bb95e77
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0025
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
filingDate 2014-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d48cefc3eb377a5c2b9dc31ff0677d19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6172931fff4109d9596a5aa8b081ff0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c459df73f2ada64e1650ee11a05db95c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a88f163cafe37b950003f254703dcbce
publicationDate 2014-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014171646-A1
titleOfInvention Non-viral gene delivery system for targeting fat cells
abstract The present invention relates to a gene delivery system for targeting fat cells and a treatment system for obesity and obesity-derived metabolic syndromes using the same and, more particularly, to a non-viral gene delivery system which directly targets a differentiated obesity (mature) fat cell and contains a fat targeting sequence (ATS)-arginine (R9) peptide.
priorityDate 2013-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004031413-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090120948-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006122118-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012074588-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226435450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421252

Total number of triples: 38.